Aclaris Therapeutics, Inc.

ACRS

NASDAQ

Healthcare

Medical - Diagnostics & Research

Wayne, PA, US61 employeesaclaristx.com

$4.16

+0.01(0.36%)

Mkt Cap $501M

$1.08

$4.53

52-Week Range

At a Glance

AI-generated

Revenue breakdown: License And Service (41.7%), Dermatology Therapeutics Segment (41.7%), Laboratory Research Revenue (8.3%).

8-K

On March 10, 2026, Aclaris Therapeutics, Inc. sold 5.7 million shares of its common stock for aggregate gross proceeds of $20.0 million pursuant to its amended and restated sales agreement with Leerink Partners LLC and Cantor Fitzgerald & Co. The shares were purchased by Frazier Life Sciences, Kalehua Capital and Adage Capital Partners LP.

$501M

Market Cap

$8M

Revenue

-$64M

Net Income

Employees61

Fundamentals

How The Business Makes Money

Revenue by Segment

License And Service41.7%($22M)

Dermatology Therapeutics Segment41.7%($22M)

Laboratory Research Revenue8.3%($4M)

Contract Research Segment8.3%($4M)

Activity

What Changed Recently

Financial Results

Feb 25, 2026

and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or oth

Regulation FD

Mar 10, 2026

shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the li

Regulation FD

Mar 8, 2026

shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the li

Regulation FD

Jan 11, 2026

and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or oth

Regulation FD

Jan 5, 2026

and Item 9.01 (including Exhibits 99.1 and 99.2) shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “ Exchange Act

Peer Companies

Company	Price	Change	Market Cap	P/E
BIOABioAge Labs, Inc.	$17.46	-1.52%	$628M	-8.8
ALLOAllogene Therapeutics, In...	$2.50	-2.54%	$608M	-2.8
SENSSenseonics Holdings, Inc.	$6.88	+3.46%	$287M	-3.9
CABACabaletta Bio, Inc.	$2.97	+10.82%	$286M	-1.2
EDITEditas Medicine, Inc.	$2.68	+2.68%	$262M	-1.3
MASS908 Devices Inc.	$6.64	+6.92%	$248M	11.4
OMIOMI	$2.68	+8.94%	$207M	—
NEONeoGenomics, Inc.	$7.97	+2.90%	$207M	-1.9

Analyst View

Company Profile

CIK0001557746

ISINUS00461U1051

CUSIP00461U105

Phone484 324 7933

Address640 Lee Road, Wayne, PA, 19087, US

SEC EDGAR